Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data

By Aebi C.   Fischer K.   Gorgievski M.   Matter L.   Muhlemann K.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3097-3103

Elsevier

Access to resources Recommend Favorite

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine

By Sato H.   Kageyama S.   Imakita M.   Ida M.   Yamamura J.-i.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1263-1269

Elsevier

Access to resources Recommend Favorite

Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine

By Sato H.   Yamamura J.-i.   Kageyama S.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

The seroprevalence of varicella zoster antibodies in Behçet's and other skin diseases

By Akdeniz Sedat   Harman Mehmet   Atmaca Selahattin   Akpolat Nezahat  

European Journal of Epidemiology, Vol. 18, Iss. 1, 2003-01 ,pp. : 91-93

Springer Publishing Company

Access to resources Recommend Favorite